Introduction
The v-myb gene was originally identified as the oncogene of the acutely oncogenic chicken retroviruses avian myeloblastosis virus (AMV) and avian leukemia virus E26 and is responsible for the ability of these viruses to transform myelomonocytic cells (for reviews, see Ness, 1996; Lipsick and Wang, 1999; Oh and Reddy, 1999) . v-myb was derived by retroviral transduction from the c-myb gene, which is highly expressed in immature hematopoietic cells and plays a crucial role in the development of the hematopoietic system. c-myb is thought to act as a genetic switch that directs hematopoietic progenitor cells to alternative fates, such as proliferation, differentiation and apoptosis (Weston, 1998; Oh and Reddy, 1999) .
The proteins encoded by the v-myb and c-myb (referred to as v-Myb and c-Myb) act as transcription factors; they recognize the consensus sequence motif PyAACG/TG (Biedenkapp et al., 1988) and activate promoters containing such binding sites (Klempnauer et al., 1989; Ness et al., 1989; Weston and Bishop, 1989; Ibanez and Lipsick, 1990) . The identification and characterization of the genes whose expression is regulated by Myb proteins is therefore crucial for understanding the role of Myb proteins in hematopoietic cells. Several genes expressed in v-myb-transformed myeloblasts have already been identified as direct targets for v-Myb, including mim-1 (Ness et al., 1989) , the lysozyme gene (Introna et al., 1990 ), bcl-2 (Frampton et al., 1996 Taylor et al., 1996) , tom-1 , c-kit (Hogg et al., 1997) , GBX2 (Kowenz-Leutz et al., 1997), Pdcd4 (Schlichter et al., 2001) , the genes for neutrophil elastase (Oelgeschla¨ger et al., 1996) , the A2B adenosine receptor . The mechanisms by which Myb proteins activate the expression of these genes have been studied in some detail, particularly for those genes whose expression within the hematopoietic system is restricted to myelomonocytic cells, such as mim-1 and tom-1. This work has shown that the CCAAT-box/enhancer binding protein beta (C/EBPb) and other members of the C/EBP family act as cooperation partners for Myb in myelomonocytic cells (Burk et al., 1993 Ness et al., 1993; Mink et al., 1996) . The cooperation between Myb and C/EBPb has been analysed in detail and appears to be mediated by direct as well as indirect interactions of both proteins (Mink et al., 1996 (Mink et al., , 1997 Tahirov et al., 2002) .
We have made the somewhat surprising observation that the C/EBPb gene itself is a Myb target gene (Mink et al., 1999) . We could show that the C/EBPb gene is autoregulated by its own gene product and that v-Myb synergizes with C/EBPb at the C/EBPb promoter, thereby stimulating an autoregulatory loop. That Myb stimulates transcription of the C/EBPb gene has been independently confirmed by a recent microarray analysis of Myb target genes (Rushton et al., 2003) . C/EBPb plays an important role in the differentiation of various cell types, such as adipocytes, hepatocytes, keratinocytes and the myelomonocytic cells of the hematopoietic system (for reviews, see Darlington et al., 1998; Lekstrom-Himes and Xanthopoulos, 1998; Yamanaka et al., 1998) . In the hematopoietic system, transcription of C/EBPb is very high in myelomonocytic cells and increases during their differentiation, while other hematopoietic cell types express little or no C/EBPb mRNA (Natsuka et al., 1992; Scott et al., 1992; Sterneck et al., 1992; Katz et al., 1993) . In addition to being regulated by Myb and C/EBPb (Chang et al., 1995; Mink et al., 1999; Niehof et al., 2001a) , the C/EBPb promoter is regulated by various extracellular signals, such as cAMP, IL-6 and LPS (Akira et al., 1990; Poli et al., 1990; Niehof et al., 1997 Niehof et al., , 2001b Lin et al., 2002) . Furthermore, C/EBPb expression is controlled posttranscriptionally by the use of alternative initiation codons that give rise to different isoforms of the protein (Calkhoven et al., 2000) as well as by phosphorylation (Metz and Ziff, 1991; Wegner et al., 1992; Nakajima et al., 1993; Trautwein et al., 1993) .
Up to now most studies on the transcriptional regulation of C/EBPb expression have focused on the promoter region of the gene. In an attempt to identify additional cis-acting sequences that control the expression of the gene in myelomonocytic cells, we have recently mapped DNase I hypersensitive sites (DHSs) in the chromatin surrounding the C/EBPb gene (Kintscher et al., 2003) . We have identified a number of such sites, most of which were specific for myelomonocytic cells. Here, we have characterized one of the DNase I hypersensitive regions in more detail. Our results show that this site acts as a Myb-dependent enhancing element in myelomonocytic cells. It therefore appears that Myb stimulates C/EBPb expression by acting on the promoter as well as on an enhancer of the C/EBPb gene.
Results
Mapping of a DNase I hypersensitive site in the 3 0 region of the chicken C/EBPb gene DHSs in the chromatin surrounding a gene in many cases have been shown to mark cis-acting DNA sequences, such as enhancers, silencers or other elements regulating the expression of that gene. Previously, we have mapped a number of DHSs in the chicken C/EBPb gene region (Kintscher et al., 2003) , most of which were specific for myelomonocytic cells, which express the gene at a high level. One of these sites, located downstream of the gene, appeared to be more prominent in the v-mybtransformed myeloblast cell line BM2 than in a myelomonocytic cell line (HD11) not expressing v-myb or c-myb (Kintscher et al., 2003) . Since the C/EBPb gene is a Myb target gene, we became interested to study this site in more detail. Because the resolution of our previous mapping studies was rather poor in the region downstream of the C/EBPb gene, we determined the position of this DHS more accurately by a new mapping experiment (Figure 1) . In this experiment, we compared the chromatin of different chicken cell lines using a hybridization probe derived from the region downstream of the C/EBPb gene. It is evident that there is a region of DNase I hypersensitivity in BM2 cells whose center is located approximately 1.2 kb from a HindIII restriction site mapping close to the 3 0 end of the C/ EBPb gene. The band generated by DNase I is relatively diffuse, suggesting that the region of nuclease hypersensitivity extends for around 200-300 bp. In HD11 cells this DHS is very weak, and in HD3 or DF-1 cells it is undetectable . Since this site is located approximately 3 kb downstream of the start of the C/EBPb gene, we will refer to it as the þ 3 kb DHS throughout this paper.
The finding that a DNase I hypersensitive region is located very close to the C/EBPb gene in v-Mybexpressing myelomonocytic cells (BM2) but not in another myelomonocytic line not expressing Myb (HD11) led us to suspect that this region might be a target site for Myb. To gather further evidence in support of this idea, we asked whether expression of v-Myb in HD11 cells would affect the structure in the þ 3 kb region. To address this question, we performed a . It thus appears that the expression of v-Myb in HD11 cells affects the local chromatin structure at the þ 3 kb DHS region, consistent with the idea that this region is a target site for Myb. The weak DHS detected in HD11 cells is probably not related to endogenous c-myb because HD11 cells do not express the gene.
Chromatin immunoprecipitation analysis reveals binding of v-Myb to the þ 3 kb C/EBPb enhancer
The data described so far suggest that v-Myb might play a role at the þ 3 kb DHS of the C/EBPb gene. To further explore this role, we examined the nucleotide sequence of this region for potential Myb binding sites. Figure 2 shows that there are indeed several Myb binding motifs within the þ 3 kb DHS. To demonstrate that the v-Myb protein is bound to this region in vivo, we performed chromatin immunoprecipitation (ChIP) experiments. We used two different Myb-specific antibodies to immunoprecipitate formaldehyde-fixed chromatin fragments from BM2 or HD11 cells. After reverse-crosslinking and isolating the DNA from the immunoprecipitates, we performed PCR reactions using primers that specifically amplify an approximately 510 bp fragment from the þ 3 kb DHS region. As illustrated in Figure 3 , ChIP analysis indeed showed that v-Myb is bound to the þ 3 kb C/EBPb DHS in BM2 cells. In HD11 cells, ChIP experiments with mybspecific antibodies were negative, as expected, thus confirming the specificity of the immunoprecipitation.
The þ 3 kb DHS functions as an enhancing element in BM2 cells
To explore the function of the þ 3 kb DHS, we cloned it upstream of the herpes simplex virus thymidine kinase (tk) promoter and the luciferase gene and transfected the resulting reporter gene into different chicken cell lines of myelomonocytic (BM2, HD11), erythroid (HD3) or fibroblastic (DF-1) origin. Figure 4 shows that the þ 3 kb DHS stimulates the activity of the tk promoter when transfected into BM2 cells, suggesting that it acts as an enhancing element. Interestingly, this element was inactive or had very low activity in the other cells. In contrast to BM2 cells, none of the other cells tested possess the þ 3 kb DHS downstream of the C/EBPb gene (see Figure 1) . Thus, our data show that there is an enhancing element located downstream of the C/EBPb gene that is specifically active in v-Myb-expressing BM2 cells, consistent with the idea that v-Myb is directly involved in the function of this element.
The enhancing activity of the þ 3 kb C/EBPb DHS is Myb-dependent
We next investigated whether v-Myb expression affects the enhancing activity of the þ 3 kb DHS. In one series of experiments, we transfected reporter plasmids containing or lacking this region into 10.4 cells, a myelomonocytic cell line expressing a fusion protein of v-Myb and the human estrogen receptor. The activity of this fusion protein can be manipulated by growing the cells in the presence or absence of b-estradiol (Burk and Klempnauer, 1991) . Figure 5a shows that the activity of the reporter plasmid containing the þ 3 kb DHS was strongly increased in the presence of b-estradiol (i.e. when the v-Myb/ER protein is active), whereas the activity of the basal tk promoter was affected much less, suggesting that the enhancing activity of the þ 3 kb C/EBPb DHS is Myb-inducible. To corroborate this finding, we cotransfected the reporter gene containing the þ 3 kb DHS with or without a v-Myb expression vector into the HD11 cell line and determined the luciferase activity. Control precipitations were performed with normal rabbit serum (lanes 3) or without antibody (lanes 4). DNA isolated from the immunoprecipitates (lanes 1-4) or from the total chromatin preparation before immunoprecipitation (lanes 6) was analysed by PCR using primers specific for the þ 3 kb C/EBPb DHS. Lane 5 shows a PCR control to which no target DNA was added. The positions of 400 and 600 bp size markers are indicated
Enhancer of the chicken C/EBPb gene J Kintscher et al Figure 5b shows that v-Myb activated the reporter gene approximately 12-fold in these cells, whereas the tk promoter itself was activated only weakly, consistent with the notion that Myb stimulates the activity of the þ 3 kb DHS. Interestingly, the stimulation of the enhancer by v-Myb was dependent on the cellular context. While Myb strongly activated the enhancer in myelomonocytic cells, it failed to do so in a fibroblast cell line (Figure 5c ). This suggests that an additional cell-specific factor might be involved in the stimulatory effect of v-Myb. In addition to demonstrating an effect of Myb in transient transfection experiments, we were interested to know whether Myb is also able to activate the enhancer when stably integrated in the cellular genome. To address this question, we generated stable transfectants of 10.4 cells carrying the reporter gene containing the tk promoter and the þ 3 kb DHS or, as a control, only the tk promoter. Pools of such cells were then grown in the presence or absence of b-estradiol followed by the analysis of the luciferase activity. We found that the activity of the reporter gene was strongly activated by b-estradiol in the stable transfectants. By contrast, the activity of the reporter gene containing only the tk promoter was virtually unaffected (Figure 5d ). Thus, Myb is also able to access the enhancer and activate the reporter gene when stably integrated into the cellular genome.
Finally, we wished to know whether the þ 3 kb enhancer also functions in the context of the promoter of the C/EBPb gene. We constructed reporter genes containing C/EBPb promoter sequences from À700 to þ 120 bp and the þ 3 kb DHS in two different orientations. The construct containing only the C/EBPb promoter was stimulated by v-Myb, consistent with previous work, which showed that Myb can directly activate the C/EBPb promoter (Mink et al., 1999) (Figure 5e ). The þ 3 kb DHS clearly increased the stimulatory effect of Myb, independent of its orientation relative to the promoter. The increase was, however, not as strong as in the case of the tk promoter. This is probably due to the fact that the C/EBPb promoter construct used is a much more powerful promoter than the tk promoter. Figure 4 Cell-specific enhancing activity of the þ 3 kb C/EBPb DHS. The luciferase reporter genes containing or lacking the þ 3 kb C/EBPb DHS are illustrated schematically at the top. The C/EBPb gene is shown as a black bar and the locations of some restriction sites are indicated (H: HindIII; S: SacI). Different chicken cell lines were transfected by calcium phosphate coprecipitation (HD11, DF-1) with 5 or 2 mg of reporter plasmids pGL3-tk-Luc-S6004 (black bars) or pGL3-tk-Luc (white bars) and 0.5 mg of the b-galactosidase reference plasmid pCMVb. BM2 and HD3 cells were electroporated using 5 mg of the indicated luciferase reporter plasmids and 2 mg of pCMVb. The cells were harvested 24 h after transfection and analysed for luciferase and b-galactosidase activity. The columns show the average luciferase activity normalized with respect to the activity of the cotransfected b-galactosidase plasmid. Thin lines show standard deviations. The activity of the reporter gene containing only the tk promoter (pGL3-tk-Luc) was designated as one We have shown before that v-Myb activates the C/EBPb promoter by cooperating with C/EBPb itself (Mink et al., 1999) . Thus, C/EBPb creates an autoregulatory loop at the promoter of its own gene, which is further stimulated by Myb. Since the experiment shown in Figure 5c suggests that v-Myb acts on the enhancer together with another factor present in the myelomonocytic line HD11 but not in fibroblasts, we were interested to know whether Myb also cooperates with C/EBPb at the þ 3 kb enhancer. We therefore compared the effects of v-Myb and C/EBPb on the activity of the C/EBPb promoter and enhancer, using the QT6 fibroblast line. These cells have been employed before to demonstrate cooperativity between Myb and C/EBPb because they have low levels of endogenous C/EBP
Enhancer of the chicken C/EBPb gene J Kintscher et al factors. Figure 6 shows that the C/EBPb promoter was stimulated synergistically by v-Myb and C/EBPb, in agreement with previous work (Mink et al., 1999) . By contrast, C/EBPb failed to stimulate the enhancer in the presence or absence of Myb. Thus, this experiment suggests that the mechanisms by which v-Myb stimulates the C/EBPb promoter and enhancer differ from each other with respect to the involvement of C/EBPb as a cooperating factor of Myb.
Discussion
DHSs are regions that are characterized by an open chromatin structure and in many cases correspond to cis-acting sequences involved in gene regulation. The mapping of DHSs, therefore, is a very powerful tool to identify potential cis-regulatory sequences of a gene of interest. By comparing the pattern of DHSs between different cell types, it is possible to identify potential cell-type-specific regulatory sequences. In this study, we have employed this strategy to identify a novel Myb target region in the C/EBPb gene, a known Myb target gene. Our success in finding a Myb-dependent enhancing element by performing chromatin structure analyses demonstrates the usefulness and the potential of this approach. In case of most Myb target genes that have been identified so far, Myb acts on the promoter of the particular gene. Only in a few cases, such as the myeloperoxidase gene (Britos-Bray and Friedman, 1997) , the T-cell receptor d and pre-T-cell receptor a genes (Hernandez-Munain and Krangel, 1994; Reizis and Leder, 2001 ) and the adenosine deaminase gene (Ess et al., 1995) have enhancers been implicated in gene activation by Myb. Together with our previous work, which showed that the C/EBPb promoter is Mybresponsive (Mink et al., 1999) , the results presented here identify the C/EBPb gene as the first Myb target gene known to be activated by Myb from two separate regions. Whether the dual regulatory mechanism, which is suggested by our studies, is a peculiarity of the C/ EBPb gene or is a more common phenomenon in the regulation of Myb target genes is open at present since in most cases only the promoter region of such genes has been analysed. It will therefore be interesting to see if our approach will reveal additional Myb-dependent cis-regulatory elements when applied to other Mybregulated genes.
Our previous work has shown that the C/EBPb promoter is activated cooperatively by Myb and C/EBPb (Mink et al., 1999) . The stimulation of the C/EBPb enhancer by Myb also appears to involve another factor. We have found that the stimulatory effect of v-Myb on the activity of the enhancer was much higher in myelomonocytic cells than in fibroblasts, suggesting that Myb might cooperate with a factor present in myelomonocytic cells but not (or only in lower levels) in fibroblasts. Interestingly, in the case of the enhancer, this factor seems to be different from C/EBPb because we did not observe any cooperativity between Myb and C/EBPb at the enhancer. Thus, although Myb appears to stimulate C/EBPb expression from two different sites of the gene, the mechanism by which Myb acts on these regions seems to be different in both cases.
The work presented here also shows for the first time directly that expression of v-Myb is able to affect the local chromatin structure leading to increased DNase I hypersensitivity. It will be interesting to find out whether this activity of v-Myb requires the cooperation with another myelomonocytic-specific factor and, if this is the case, whether this factor is identical with the one required by Myb to stimulate the transcriptional activity of the enhancer.
C/EBPb is a member of the CCAAT box/enhancer binding protein family and plays an important role during differentiation of a number of cell types, including liver cells, fat cells and myelomonocytic cells (Darlington et al., 1998; Lekstrom-Himes and Xanthopoulos, 1998; Yamanaka et al., 1998) . C/EBPb is highly expressed in these cell types and is involved in the activation of specific genes as part of the differentiation program of these cell types (Cao et al., 1991; Natsuka et al., 1992; Scott et al., 1992; Katz et al., 1993; Yeh et al., 1995; Chumakov et al., 1997) . Within the hematopoietic system, transcription of the C/EBPb gene is highly specific for cells committed to the myelomonocytic lineage (Sterneck et al., 1992; Katz et al., 1993) . Previous work has shown that C/EBPb cooperates with Myb to activate a number of genes specifically expressed in myelomonocytic cells, such as mim-1, tom-1, the lysozyme and neutral elastase genes and presumably others. The finding that the C/EBPb gene itself is a Mybregulated gene (Mink et al., 1999; Rushton et al., 2003; this work) shows that the relationship between Myb and C/EBPb is more complex than C/EBPb simply being a cooperating transcription factor. It appears that in myelomonocytic cells Myb acts at several levels to activate myelomonocytic-specific genes: Myb cooperates with C/EBPb to activate directly the expression of a set of target genes, including mim-1, tom-1 and others. In addition, Myb stimulates expression of the C/EBPb gene and thereby increases the expression of its cooperation partner. This, in turn, may result in increased expression of other Myb target genes. Finally, the possible relevance of activating the expression of the C/EBPb gene by Myb from two different regulatory sites should be considered. Our data show that the mechanisms by which Myb acts on the C/EBPb promoter and enhancer differ with respect to the requirement of C/EBPb as a cooperation partner of Myb. We hypothesize that both elements might be important at different times during hematopoietic differentiation. Early hematopoietic cells not yet committed to the myelomonocytic lineage express Myb but not C/EBPb. In these cells, Myb in conjunction with other as yet unknown factors might activate the C/EBPb gene by acting primarily on the enhancer. Once C/EBPb is expressed at low levels, an autoregulatory loop, which is stimulated by Myb, is established at the promoter of the gene, leading to higher levels of C/EBPb expression, which will eventually become Myb-independent in fully differentiated cells no longer expressing Myb. In the light of this model, it will be very interesting to identify the factors that cooperate with Myb at the C/EBPb enhancer and to investigate whether these factors play a role in the commitment of progenitor cells to the myelomonocytic lineage.
Materials and methods

Cells
HD11 is a line of MC29-transformed chicken macrophages and was grown in basal Iscoves' medium supplemented with 8% fetal calf serum and 2% chicken serum. 10.4 is a subclone of the HD11 line expressing a v-Myb/estrogen receptor fusion protein (Burk and Klempnauer, 1991) . H26.1 is a subclone of the HD11 cell line stably expressing the v-Myb protein of AMV . BM2 is a line of AMV-transformed chicken myeloblasts grown in RPMI 1640 medium supplemented with 5% fetal calf serum, 5% chicken serum and 10% tryptone phosphate broth (Gibco). HD3 is a line of AEVtransformed chicken erythroblasts grown in RPMI 1640 medium supplemented with 8% fetal calf serum and 2% chicken serum. DF-1 is a chicken fibroblast cell line (Himly et al., 1998) and was grown in DMEM supplemented with 10% fetal calf serum. QT6 is a line of chemically transformed Japanese quail fibroblasts (Moscovici et al., 1977) and was grown in basal Iscoves' medium supplemented with 8% fetal calf serum and 2% chicken serum.
Mapping of DNaseI hypersensitive sites
DHSs were mapped according to Sippel et al. (1996) . Genomic DNA was digested with HindIII. Southern blots were analysed with a probe derived from an approximately 0.8 kb DNA region from the downstream region of the chicken C/EBPb gene (see Figure 1 for exact location of the probe region).
Reporter genes and transfections
The luciferase reporter gene pGL3-tk-Luc containing tk promoter sequences from À81 to þ 53 bp has been described (Kintscher et al., 2003) . Plasmid pGL3-tk S6004 was obtained by cloning a 0.6 kb SacI fragment from downstream of the C/EBPb gene and containing the þ 3 kb DHS region into the SacI site of pGL3-tk-Luc. The luciferase reporter plasmid pCCR-700Luc contains C/EBPb promoter sequences from À700 to þ 120 bp and has been described before (Mink et al., 1999) . Plasmids prS6004-CCR-700Luc and pS6004-CCR-700-Luc were generated by cloning a 0.6 kb SacI fragment into the SacI site in front of the C/EBPb promoter sequence of pCCR700Luc. The b-galactosidase reporter gene pCMVb was obtained from Clontech. DNA transfection was performed by calcium phosphate co-precipitation or by electroporation, as described previously (Kintscher et al., 2003) . Cells were harvested 24 h after transfection and analysed for luciferase and b-galactosidase activity as previously described (Burk et al., 1993) .
Chromatin immunoprecipitation
ChIP assays were performed as follows: 10 8 cells were incubated at room temperature with 1/10 crosslinking solution (11% formaldehyde; 50 mM Tris-HCl, pH 8.0; 0.1 M NaC1; 1 mM EDTA; 0.5 mM EGTA) for 1 h and quenched for 5 min with 125 mM glycine. After washing twice with ice-cold phosphate-buffered saline, cells were treated for 20 min each with washing solutions A (0.25% Triton X-100; 10 mM TrisHCl, pH 8.0; 10 mM EDTA; 0.5 mM EGTA) and B (200 mM NaCl, 50 mM Tris-HCl, pH 8.0; 1 mM EDTA; 0.5 mM EGTA). Nuclei were sonicated on ice (four times for 20 s each in 2 min intervals) in egg lysis buffer (ELB) (120 mM NaCl; 50 mM TrisHCl, pH 7.5; 20 mM NaF; 1 mM EDTA; 6 mM EGTA; 15 mM sodium pyrophosphate; 1 mM phenylmethylsulfonyl fluoride; 0.1% NP-40). The DNA-protein complexes were preincubated with protein A-sepharose for 1 h at 41C on a rotating wheel and after centrifugation the supernatant was incubated with Myb-specific monoclonal antibody 5E11 (Sleeman, 1993) , polyclonal antiserum raised against the DNA binding domain of v-Myb (Klempnauer et al., 1986) , normal rabbit serum or water overnight at 41C on a rotating wheel. After precipitating with protein A-sepharose, the samples were washed eight times in ELB buffer. The immunoprecipitates were eluted with elution buffer 1 (10 mM Tris-HCl, pH 7.5; 0.5% SDS; 10 mM DTT) and elution buffer 2 (10 mM Tris-HCl, pH 7.5; 1% SDS). The eluates were combined and the DNA was recovered by reverse-crosslinking for 6 h each at 37 and 651C, respectively, in a buffer containing 0.5% SDS, 10 mM DTT and 100 mg proteinase K. The immunoprecipitated DNA was extracted by phenol-chloroform, ethanol precipitated, resuspended in 150 ml of 10 mM Tris-HCl, pH 7.5, and stored at À201C. PCR was performed by using the following primers: upper strand, TCTCCTCTACCTCAGCCCTC; lower strand, GAGCTCTCAGGGAGATCTGC. PCR products were resolved on a 2% agarose gel and stained with ethidium bromide.
